Anguraj Sadanandam Selected Research

Anguraj Sadanandam Research Topics

Disease

32	Neoplasms (Cancer) 11/2022 - 01/2007
10	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2007
9	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 05/2013
8	Breast Neoplasms (Breast Cancer) 09/2020 - 07/2008
3	Melanoma (Melanoma, Malignant) 01/2019 - 04/2009
3	Osteolysis 01/2009 - 07/2008
2	Microsatellite Instability 11/2022 - 11/2015
2	Adenocarcinoma 11/2021 - 04/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 09/2010
2	Rectal Neoplasms (Rectal Cancer) 01/2021 - 01/2017
1	Cytokine Release Syndrome 12/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Disease Progression 01/2020
1	Inflammation (Inflammations) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2015
1	Carcinogenesis 12/2014
1	Margins of Excision 12/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2007

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2010
4	LigandsIBA 09/2021 - 01/2007
4	Pharmaceutical PreparationsIBA 09/2020 - 02/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2010
3	Calcibiotic Root Canal SealerIBA 11/2022 - 01/2019
3	Biological ProductsIBA 09/2020 - 01/2017
3	Messenger RNA (mRNA)IBA 12/2015 - 01/2010
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2009
2	MicroRNAs (MicroRNA)IBA 11/2021 - 12/2015
2	CytokinesIBA 01/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2019
2	InterferonsIBA 07/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2019 - 01/2019
2	Estrogen ReceptorsIBA 01/2019 - 01/2010
2	Semaphorins (Semaphorin)IBA 12/2014 - 09/2010
2	Proteins (Proteins, Gene)FDA Link 09/2010 - 01/2007
2	Small Interfering RNA (siRNA)IBA 01/2010 - 01/2010
2	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2009 - 01/2009
2	RANK LigandIBA 01/2009 - 07/2008
2	Cell Adhesion MoleculesIBA 01/2008 - 01/2007
1	Immune Checkpoint InhibitorsIBA 11/2022
1	folfirinoxIBA 11/2021
1	Fluorouracil (Carac)FDA LinkGeneric 11/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021
1	CannabinoidsIBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Etoposide (VP 16)FDA LinkGeneric 09/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2020
1	Biological FactorsIBA 01/2020
1	Conditioned Culture MediaIBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	ceralasertibIBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	trametinibIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	PlasticsIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2010
1	Genetic Markers (Genetic Marker)IBA 12/2009
1	(N(1),N(12))bis(ethyl)- 6,7- dehydrospermineIBA 12/2009
1	PolyaminesIBA 12/2009
1	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA 04/2009
1	2-Hydroxypropyl-beta-cyclodextrinIBA 04/2009
1	SCH 479833IBA 04/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2009
1	Antisense OligonucleotidesIBA 01/2009
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2009
1	Neutralizing AntibodiesIBA 01/2009
1	Cathepsin GIBA 07/2008
1	Matrix Metalloproteinases (MMPs)IBA 07/2008
1	Peptide Hydrolases (Proteases)FDA Link 07/2008
1	Complementary DNA (cDNA)IBA 07/2008
1	Cathepsin KIBA 07/2008
1	ChemokinesIBA 12/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2007
1	plexinIBA 01/2007
1	Peptides (Polypeptides)IBA 01/2007

Therapy/Procedure

9	Therapeutics 01/2020 - 01/2009
3	Radiotherapy 01/2021 - 01/2010
1	Drug Therapy (Chemotherapy) 11/2021
1	Neoadjuvant Therapy 01/2021
1	Immunotherapy 01/2019
1	Precision Medicine 01/2019
1	Chemoradiotherapy 01/2017
1	Segmental Mastectomy (Lumpectomy) 12/2012